Sponsor or institution
Clinical trials and research at Mirador Therapeutics, Inc.
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Mirador Therapeutics, Inc. that are recruiting, at sites in 5 countries (most in United States (4), Canada (1), Georgia (1)). By phase: Phase 1 (3), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 5Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Single-dose MT-201 with Infliximab in healthy adults | Phase 1 | San Diego, California | Recruiting | Aug 20, 2026 |
| First-in-human single and multiple ascending dose testing of MT-251 in healthy adults | Phase 1 | San Diego, California | Recruiting | Feb 20, 2026 |
| First human testing of single and multiple ascending doses of MT-201. | Phase 1 | San Diego, California | Recruiting | Oct 21, 2025 |
| Phase 2 testing of new therapies for moderate-to-severe inflammatory bowel disease | Phase 2 | Birmingham, Alabama and 65 other locations | Recruiting | Aug 8, 2025 |
All recruiting trials (4)
-
Single-dose MT-201 with Infliximab in healthy adults
This early phase study tests a single dose of MT-201 given with infliximab in healthy adults to see if it is safe and how the body handles it.
-
First-in-human single and multiple ascending dose testing of MT-251 in healthy adults
This study will test whether MT-251 is safe, well tolerated, and how the body handles it in healthy adults aged 19–55.
-
First human testing of single and multiple ascending doses of MT-201.
This will test whether single and multiple doses of MT-201 are safe, tolerated, and how the body processes them in healthy adults aged 19–55.
-
Phase 2 testing of new therapies for moderate-to-severe inflammatory bowel disease
The study will try two experimental medicines, MT-501 and MT-201, to see if they are safe and help adults with moderately to severely active Crohn's disease or ulcerative colitis.
Quick answers
How many clinical trials run by Mirador Therapeutics, Inc. are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (4 trials), Canada (1 trial), Georgia (1 trial), Moldova (1 trial), Ukraine (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.